发明名称 MEDICINAL COMPOSITION FOR TRANSDERMAL ABSORPTION, MEDICINAL COMPOSITION STORING UNIT AND TRANSDERMAL ABSORPTION PREPARATION USING THE SAME
摘要 <p>It is intended to provide a transdermal absorption preparation capable of sustaining the blood morphine concentration at the effective level over at least 48 hours, etc. This transdermal absorption preparation comprises a medicinal composition for transdermal absorption in which an active ingredient selected from among morphine and salts thereof is blended in such an amount as corresponding to the saturation solubility or more with an active ingredient-holding vehicle having fluidity at a temperature around the human skin surface temperature and at least a portion of the active ingredient is held as crystals, characterized in that, in the case where a preparation obtained from the above-described medicinal composition for transdermal absorption is applied to the uninjured back of a white rabbit having been shaven with electrical clippers for 72 hours, the available dose of the active ingredient per single dose of the preparation is from 10 mg to 400 mg in terms of morphine base, and the plasma concentrations of the active ingredient 24 hours and 48 hours after the application of the preparation under the above-described conditions are each at least 40 ng/mL in terms of morphine base, and so on.</p>
申请公布号 KR20090116816(A) 申请公布日期 2009.11.11
申请号 KR20097020394 申请日期 2008.02.29
申请人 TEIKA PHARMACEUTICAL CO., LTD. 发明人 KIMURA TAKAHITO;ORIHASHI MASAHIRO;FUJISHITA SHIGETO;TAKABATAKE KOICHI;KATO TATSUHISA;SHIOTA SATOSHI;SHIMA YUICHIRO
分类号 A61K31/485;A61K9/00;A61K47/08;A61P25/04 主分类号 A61K31/485
代理机构 代理人
主权项
地址